Evidence map›Paper›PMID 40999798›Full record

ReviewPsychological medicine2025

Neuromodulation and neural networks in psychiatric disorders: current status and emerging prospects.

Panayiota G Michalopoulou, Kyrillos M Meshreky, Zoe Hommerich, Sukhi S Shergill

Abstract readReview
In one paragraph

Review in Psychological medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Panayiota G MichalopoulouDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), https://ror.org/0220mzb33King's College London, London, UK.ORCID 0009-0003-9776-409X
Kyrillos M MeshrekyDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), https://ror.org/0220mzb33King's College London, London, UK.
Zoe HommerichDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), https://ror.org/0220mzb33King's College London, London, UK.
Sukhi S ShergillDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), https://ror.org/0220mzb33King's College London, London, UK.

Funding

Medical Research Council MR/V037218/1Wellcome TrustWellcome Trust 227012/Z/23/Z
6 · The paper itself

Abstract

Psychiatric disorders lead to disability, premature mortality and economic burden, highlighting the urgent need for more effective treatments. The understanding of psychiatric disorders as conditions of large-scale brain networks has created new opportunities for developing targeted, personalised, and mechanism-based therapeutic interventions. Non-invasive brain stimulation (NIBS) techniques, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), can directly modulate dysfunctional neural networks, enabling treatments tailored to the individual's unique functional network patterns.As NIBS techniques depend on our understanding of the neural networks involved in psychiatric disorders, this review offers a neural network-informed perspective on their applications. We focus on key disorders, including depression, schizophrenia, and obsessive-compulsive disorder, and examine the role of NIBS on cognitive impairment, a transdiagnostic feature that does not respond to conventional treatments. We discuss the advancements in identifying NIBS response biomarkers with the use of electrophysiology and neuroimaging, which can inform the development of optimised, mechanism-based, personalised NIBS treatment protocols.We address key challenges, including the need for more precise, individualised targeting of dysfunctional networks through integration of neurophysiological, neuroimaging and genetic data and the use of emerging techniques, such as low- intensity focused ultrasound, which has the potential to improve spatial precision and target access. We finally explore future directions to improve treatment protocols and promote widespread clinical use of NIBS as a safe, effective and patient-centred treatment for psychiatric disorders.

Indexed as

BrainMental DisordersNerve NetSchizophreniaTranscranial Direct Current StimulationTranscranial Magnetic StimulationHumansObsessive-Compulsive DisorderBiomarkersCognitionDepressionFocused ultrasound stimulation (FUS)Neural networksNon-invasive brain stimulation (NIBS)Obsessive-compulsive disorderPrecision psychiatryPsychiatric disordersSchizophreniaTranscranial alternating current stimulation (tACS)Transcranial direct current stimulation (tDCS)Transcranial magnetic stimulation (TMS)

Identifiers

PMID40999798
PMCPMC12527521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.